Page - (000260) - in Biomedical Chemistry: Current Trends and Developments

Journal, 13, 418-424. Bals, R.; Wang, X.; Zasloff, M.; Wilson, J. M. (1998). The peptide antibiotic ll-37/hcap-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proceedings of the National Academy of Sciences of USA, 95, 9541-9546. Beevers, A. J.; Dixon, A. M. (2010). Helical membrane peptides to modulate cell function. Chemical Society Reviews, 39, 2146-2157. Bell, A. (2011). Antimalarial peptides: the long and the short of it. Current Pharmaceutical Design, 17, 2719-2731. Bellis, S. L. (2011). Advantages of RGD peptides for directing cell association with biomaterials. Biomaterials, 32, 4205-4210. Bertoloni, A.; Ferrari, A.; Ottani, A.; Guerzoni, S.; Tacchi, R.; Leone, S. (2006). Paracetamol: new vistas of an old drug. CNS Drug Reviews, 12, 250-275. Birolo, L.; Sandmeier, E.; Christen, P.; John, R. A. (1995). The roles of Tyr70 and Tyr225 in aspartate aminotransferase assessed by analysing the effects of mutations on the multiple reactions of the subtrate analogue serine o-sulphate. European Journal of Biochemistry, 232, 859-864. Boer, A. G.; Gaillard, P. J. (2007a). Drug targeting to the brain. Annual Review of Pharmacology and Toxicology, 47, 323-355. Boer, A. G.; Gaillard, P. J. (2007b). Strategies to improve drug delivery across the blood-brain barrier. Clinical Pharmacokinetics, 46, 553-576. Bode, S. A.; Wallbrecher, R.; Brock, R.; van Hest, J. C. M.; Löwik, D. W. P. M. (2014). Activation of cell-penetrating peptides by disulfide bridge formation of truncated precursors. Chemical Communications, 50, 415-417. Boman H. G. (2003). Antibacterial peptides: basic facts and emerging concepts. Journal of Internal Medicine, 254, 197-215. Borissova, R.; Lammek, B.; Stjärnkvist, P.; Sjöholm, I. (1995). Biodegradable microspheres. 16. Synthesis of primaquine–peptide spacers for lysosomal release from starch microparticles. Journal of Pharmaceutical Sciences, 84, 249-255. Bradshaw, T. D.; Bibby, M. C.; Double, J. A.; Fichtner, I.; Cooper, P. A.; Alley, M. C.; Donohue, S.; Stinson, S. F.; Tomaszewjski, J. E.; Sausville, E. A.; Stevens, M. F. (2002). Preclinical evaluation of amino acid prodrugs of novel antitumor 2-(4-amino-3- methylphenyl)benzothiazoles. Molecular Cancer and Therapy, 1, 239-246. Brady, S. F.; Pawluczyk, J. M.; Lumma, P. K.; Feng, D. M.; Wai, J. M.; Jones, R.; DeFeo-Jones, D.; Wong, B. K.; Miller-Stein, C.; Lin, J. H.; Oliff, A.; Freidinger, R. M.; Garsky, V. M. (2002). Design and synsthesis of a pro-drug of vinblastine targeted at treatment of prostate cancer with enhanced efficacy and reduced systemic toxicity. Journal of Medicinal Chemistry, 45, 4706-4715. Bray, B. L. (2003). Large-scale manufacture of peptide therapeutic by chemical synthesis. Nature Reviews Drug Discover, 2, 587-293. Bulet, P.; Hetru, C.; Dimarcq, J. L.; Hoffmann, D. (1999). Antimicrobial peptides in insects; structure and function. Developmental and Comparative Immunology, 23, 329-344. Bundgaard, H.; Larsen, C.; Thorbek, P. (1984). Prodrugs as drug delivery systems XXVI. Preparation and enzymatic hydrolysis of various water-soluble amino acid esters of metronidazole. International Journal of Pharmaceutics, 18, 67-77.